Beryl Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$52.9M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$47.8M |
| 3 |
RST
ROSETTA STONE INC
RST
|
+$37.7M |
| 4 |
Clover Health Investments
CLOV
|
+$29.4M |
| 5 |
CANO
Cano Health, Inc.
CANO
|
+$24.3M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.61% |
| 2 | Technology | 11.53% |
| 3 | Industrials | 8.65% |
| 4 | Financials | 4.49% |
| 5 | Consumer Discretionary | 3.95% |
Similar funds
Beryl Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Beryl Capital Management held 135 positions worth $556M, up 5.6% from $526M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Beryl Capital Management withdrew a net $42.2M in Q3 2020, closing 40 positions and reducing 5 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 4.2% a quarter earlier, followed by Technology and Industrials.
Against the trend, Beryl Capital Management opened a new position in Immunomedics Inc worth $89M.
- Beryl Capital Management's largest Q3 2020 buy was Immunomedics Inc: 1,046,632 shares worth $89M.
- Beryl Capital Management added most to Clover Health Investments, Corp. Warrants in Q3 2020, an estimated $3.18M increase.
- Beryl Capital Management's biggest Q3 2020 reduction was Social Capital Hedosophia Holdings Corp. III Units, each consisting of one Class A ordinary share an, cutting an estimated $48M.
- Beryl Capital Management fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $181M.
- Beryl Capital Management's ten largest holdings make up 62% of its $556M portfolio in Q3 2020.
- Beryl Capital Management opened 78 new positions and closed 40 in Q3 2020.
- Beryl Capital Management's portfolio value rose 5.6% quarter-over-quarter to $556M.
Based on Beryl Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.